Skip to content
APOAPOAPOOLAOLAOLA2.52.52.5

Drawing based on the label description. No photo yet.

“Olanzapine Tablets, USP are available as follows: Olanzapine Tablets, USP 2.5 mg are white, round, biconvex film-coated tablets, engraved "APO" on one side, "OLA" over "2.5" on the other side”

APO OLA 2 5 pill

Pill with imprint APO OLA 2 5 is white, round, 6 mm and has been identified as Olanzapine 2.5 mg. It is used for bipolar disorder, schizophrenia and psychosis. It is supplied by Proficient Rx LP.

Olanzapine 2.5 mg

Imprint
APO OLA 2 5
Strength
2.5 mg
Used for
Bipolar disorder, schizophrenia and psychosis
Color
White
Shape
Round
Size
6 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Proficient Rx LP
Drug class
Antipsychotic (atypical)
NDC
63187-453, 60505-3110, 63187-453-30, 60505-3110-3, 60505-3110-8, 60505-3110-0, 60429-620, 60429-620-30, 60429-620-10, 70518-3568, 70518-3568-0, 55154-6693, 55154-6693-0

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Olanzapine pills and guides

What is Olanzapine used for?

Olanzapine is used for bipolar disorder, schizophrenia and psychosis.

Medicine type
Antipsychotic (atypical)
Official uses from the US prescribing label

Schizophrenia

Oral olanzapine tablets are indicated for the treatment of schizophrenia. Efficacy was established in three clinical trials in adult patients with schizophrenia: two 6-week trials and one maintenance trial. In adolescent patients with schizophrenia (ages 13 to 17), efficacy was established in one 6-week trial.

When deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. Clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents.

Bipolar I Disorder (Manic or Mixed Episodes)

Monotherapy — Oral olanzapine tablets are indicated for the acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. Efficacy was established in three clinical trials in adult patients with manic or mixed episodes of bipolar I disorder: two 3- to 4-week trials and one monotherapy maintenance trial. In adolescent patients with manic or mixed episodes associated with bipolar I disorder (ages 13 to 17), efficacy was established in one 3-week trial.

When deciding among the alternative treatments available for adolescents, clinicians should consider the increased potential (in adolescents as compared with adults) for weight gain and dyslipidemia. Clinicians should consider the potential long-term risks when prescribing to adolescents, and in many cases this may lead them to consider prescribing other drugs first in adolescents.

Adjunctive Therapy to Lithium or Valproate — Oral olanzapine tablets are indicated for the treatment of manic or mixed episodes associated with bipolar I disorder as an adjunct to lithium or valproate. Efficacy was established in two 6-week clinical trials in adults. The effectiveness of adjunctive therapy for longer-term use has not been systematically evaluated in controlled trials.

Special Considerations in Treating Pediatric Schizophrenia and Bipolar I Disorder

Pediatric schizophrenia and bipolar I disorder are serious mental disorders; however, diagnosis can be challenging. For pediatric schizophrenia, symptom profiles can be variable, and for bipolar I disorder, pediatric patients may have variable patterns of periodicity of manic or mixed symptoms. It is recommended that medication therapy for pediatric schizophrenia and bipolar I disorder be initiated only after a thorough diagnostic evaluation has been performed and careful consideration given to the risks associated with medication treatment. Medication treatment for both pediatric schizophrenia and bipolar I disorder should be part of a total treatment program that often includes psychological, educational and social interventions.

Olanzapine Tablets and Fluoxetine in Combination: Depressive Episodes Associated with Bipolar I Disorder

Oral olanzapine tablets and fluoxetine in combination is indicated for the treatment of depressive episodes associated with bipolar I disorder, based on clinical studies. When using olanzapine tablets and fluoxetine in combination, refer to the Clinical Studies section of the package insert for Symbyax.

Olanzapine monotherapy is not indicated for the treatment of depressive episodes associated with bipolar I disorder.

Olanzapine Tablets and Fluoxetine in Combination: Treatment Resistant Depression

Oral olanzapine and fluoxetine in combination is indicated for the treatment of treatment resistant depression (major depressive disorder in patients who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode), based on clinical studies in adult patients. When using olanzapine and fluoxetine in combination, refer to the Clinical Studies section of the package insert for Symbyax.

Olanzapine monotherapy is not indicated for the treatment of treatment resistant depression.

From the FDA-approved label on DailyMed (published Sep 24, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows APO and the other side shows OLA 2.5.
  • It is white, round, 6 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Olanzapine

Inactive: Lactose Monohydrate, Microcrystalline Cellulose, Starch, Corn, Hypromellose 2910 (6 Mpa.s), Magnesium Stearate, Hydroxypropyl Cellulose (1600000 Wamw), Polyethylene Glycol, Unspecified, Titanium Dioxide

Also distributed by

Apotex Corp., Golden State Medical Supply, Inc., Remedyrepack Inc., Cardinal Health 107, LLC

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Olanzapine pills